Skip to content

Neil Lerner, Chief Accounting Officer at Compass Therapeutics, bought CMPX on Sep 24, 2026

Data as of Oct 16

▲ BUY$2.9K2,500 shares at $1.14Neil Lerner Chief Accounting OfficerCMPX Compass Therapeutics, Inc.
Watch CMPX
Traded
Sep 24, 2026
Disclosed
Sep 25, 2026
Filed
1 day after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Neil Lerner, Chief Accounting Officer at Compass Therapeutics, bought CMPX on Sep 24, 2026TRADEDDISCLOSED
CMPXSimilar stocks (XLV — its sector index fund), rebased to CMPX's price on the disclosure day
CMPX since disclosure
−23.9%
Similar stocks (XLV) since disclosure
+3.5%
XLV — its sector index fund

Change in closing price from Sep 25, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on CMPX →